Financials
- Market Capitalization 3.54 B
- Employee 10 K
- Founded N/A
- CEO N/A
- Website www.organon.com
- Headquarter New Jersey, United States
- FIGI BBG00ZQRGW24
- Industry Fabricants de Médicaments — Généralités
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
6.37
ratio cours/chiffre d'affaires
0.25
Dividende par action
0.02
Rendement du dividende (%)
6.68
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1311 | ORKA Oruka Therapeutics, Inc. - Common Stock | 86.65 USD | -0.94% | +1.06% | +26.68% | +170.19% | 5.23 B USD | ||
| 1320 | MANE Veradermics, Incorporated Common Stock | 123.70 USD | +12.57% | +6.46% | +35.68% | +274.85% | 5.17 B USD | ||
| 1754 | MBX MBX Biosciences, Inc. - Common Stock | 60.68 USD | +7.23% | -1.78% | +51.21% | +388.17% | 2.89 B USD | ||
| 1926 | PVLA Palvella Therapeutics, Inc. - Common Stock | 151.97 USD | +1.53% | +4.37% | +36.81% | +105.78% | 2.18 B USD |